Clinical and Pathological Characteristics of Aggressive Natural Killer Cell Leukemia Patients
Li-Ping WANG; Ya-Ping YU; Jian-Gang MEI; Ping SONG; Zhi-Ming AN; Xiao-Gang ZHOU.
Journal of Experimental Hematology
; (6): 1093-1100, 2021.
Artículo en Zh | WPRIM | ID: wpr-888523
Documentos relacionados
[Large granular lymphocytic leukemia and its association with immune dysregulation].
Tγδ LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients.
Natural Killer Cell Activity Test Helps to Suspect Aggressive Natural Killer Cell Leukemia - Diagnostic Challenge.
The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin-transferrin receptor 1 axis.
Pro-inflammatory cells sustain leukemic clonal expansion in T-cell large granular lymphocyte leukemia.
[A particular presentation of a T cell large granular lymphocytic leukaemia].
[Clinical and Pathological Characteristics of Aggressive Natural Killer Cell Leukemia Patients].
Effective treatment with the selective cytokine inhibitor BNZ-1 reveals the cytokine dependency of T-LGL leukemia.
STAT3 gain-of-function mutations connect leukemia with autoimmune disease by pathological NKG2D<sup>hi</sup> CD8<sup>+</sup> T cell dysregulation and accumulation.
Large Granular Lymphocytic Leukemia: Current State of Diagnosis, Pathogenesis and Treatment.